Is Aerie going out of business?

Discussion in 'Aerie Pharma' started by anonymous, Jul 23, 2020 at 11:33 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Great job Vince and Tom,

    My $46 share price is down to 12.70/share. I wonder if you both cashed out at the highs
     

  2. anonymous

    anonymous Guest

    Go sell you POS... if u could sell our stock would be higher!!!
     
  3. anonymous

    anonymous Guest

    The board needs to clean house all the way down to the RD level. This is a collection of rejects and/or retired retreads from other companies. This company was on this path prior to Covid so don't blame that.
     
  4. anonymous

    anonymous Guest

    Down to RD level? We have some of the worst immediate mgrs ever! No training, no mgt dev, no experience, no clue and half of the newer hired mgrs couldn’t sell and somehow hired on as mgrs. There’s a few that really should be looked at for incompetence and the hiring RD should be embarrassed.
     
  5. anonymous

    anonymous Guest

    I guess that's why Tom sold 190k shares at an average price of $61

    $11,500,000 is not too shabby
    It would have been $2.3M today.

    Believe in the company they said.....
     
  6. anonymous

    anonymous Guest

    Sorry I stopped too soon
     
  7. anonymous

    anonymous Guest

    Agreed...At least get rid of the Southeast RD and some of those she hired...
     
  8. anonymous

    anonymous Guest

    Many analysts saying that stock will be under $10 very soon... that is what happens when investors are told by our CEO and CFO that our share would be over 30% by now... then to bolster sales they hire an inexperienced complete buffoon in Evan to try and lead the sales force to glory...
     
  9. anonymous

    anonymous Guest

    Be wary of Vince & Tom (Ista Pharma History)

    Both said they wouldn't sell Ista for under $40/share - hello B & L $9
    Both said a generic would not impact business - guess what happened.

    Kickbacks and bundling pricing = Ista entered a guilty plea to federal felony charge of conspiracy
    ISTA agreed to pay $33.5 million to resolve criminal and civil liability arising from its marketing, distribution and sale of its drug Xibrom. Who paid ? The shareholder with a reduced stock price sale.

    Great work guys. But hey you made your big bucks. On to Aerie....

    Aerie hit $75/share and tom sold 11.2M at $61 - stock has been dropping ever since. Its not Covid. Its the company.
     
  10. anonymous

    anonymous Guest

    Wait till they have to raise more money and dilute the stock even more.
     
  11. anonymous

    anonymous Guest

    Yes. We probably will because we have a terrible sales force that can't sell two great products we handed to them with a bow. We are overpaying for you reps and hopefully we will get rid of more of you and hire reps who may have less experience but we can pay them well below 100k. Won't be any worse than the ones we are paying much more to.
     
  12. anonymous

    anonymous Guest


    So that saves a couple million is that going to make the company attractive to investors?
     
  13. anonymous

    anonymous Guest

    Keep in mind a-hole that when you feel one segment of the organization is overpaid the entire company is overpaid....
     
  14. anonymous

    anonymous Guest

    Our corporate bonus is predicated on earnings... sales suck so our bonus does also... sales reps here are overpaid not all of us in the company
     
  15. anonymous

    anonymous Guest

    So why do sales and earning suck soooo much pretty much across the board?
    Maybe , just maybe, corporate overestimated just a bit cause they have no idea or experience for what they are doing????
    just maybe?
     
  16. anonymous

    anonymous Guest

    What happened to capturing 30% of the market?
    You were off a decimal.
     
  17. anonymous

    anonymous Guest

    what happened to capturing 30% of the market.
    Hey, you were off a digit.
     
  18. anonymous

    anonymous Guest

    Our product couldn't beat Timolol at multiple time points and turns patients eyes blood red. That could have something to do with our Market Share
     
  19. anonymous

    anonymous Guest

    Lumigan has been on the market for eons. They had at the most a10 percent share
     
  20. anonymous

    anonymous Guest

    Our Glaucoma drops did wonders for Lumify Sales...